|Fourth||Fourth||Year Ended||Year Ended|
|Quarter||Quarter||Dec. 31,||Dec. 31,|
|$ in millions, except EPS amounts||2013||2012||2013||2012|
|Non-GAAP EPS that excludes items listed below 1||0.88||0.83||3.49||3.82|
|GAAP Net Income 2||781||908||4,404||6,168|
|Non-GAAP Net Income that excludes items listed below 1,2||2,599||2,540||10,443||11,743|
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2013.
Non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the fourth quarter of $0.88 and $3.49 for the full year of 2013 exclude acquisition-related costs, restructuring costs and certain other items.